About ResMed Inc. (CHESS)
-logo.jpg "ResMed Inc. (CHESS) logo")
ResMed Inc. is a holding company. The Company, through its subsidiaries, designs, manufactures and markets equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, including obstructive sleep apnea. The Company develops a range of products for sleep-disordered breathing and other respiratory disorders, including airdevices, informatics solutions, diagnostic products, mask systems, headgear and other accessories. The Company owns interest in Inova Labs Inc., a medical device company specializing in the development and commercialization of oxygen therapy products. The Company holds interest in Brightree LLC, a provider of business management and clinical software applications for the post-acute care industry. The Company's manufacturing operations are located in Australia, Singapore, France, Germany, Malaysia and the United States.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Exchange: ASX
- Symbol: RMD
- CUSIP:
Key Metrics:
- Previous Close: $6.34
- 50 Day Moving Average: $8.79
- 200 Day Moving Average: $8.26
- Trailing P/E Ratio: 34.06
- P/E Growth: 0.00
- Market Cap: $11.93B
Additional Links:
Consensus Ratings for ResMed Inc. (CHESS) (ASX:RMD) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for ResMed Inc. (CHESS) (ASX:RMD)
Show:
| Date | Firm | Action | Rating | Price Target | Details |
|---|
| 3/16/2015 | Deutsche Bank AG | Reiterated Rating | Hold | |  |
(Data available from 10/1/2014 forward)
Earnings History for ResMed Inc. (CHESS) (ASX:RMD)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for ResMed Inc. (CHESS) (ASX:RMD)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for ResMed Inc. (CHESS) (ASX:RMD)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for ResMed Inc. (CHESS) (ASX:RMD)
No insider trades for this company have been tracked by MarketBeat.com
Latest Headlines for ResMed Inc. (CHESS) (ASX:RMD)| Date | Headline |
|---|
 | 4 ASX shares to help you to an early retirement (ASX:RMD)
www.fool.com.au - September 29 at 12:13 PM |
| 3 growth shares I’d buy with $10,000 today (ASX:RMD)
www.fool.com.au - September 16 at 6:50 PM |
 | ETF’s with exposure to ResMed, Inc. : September 14, 2016 (ASX:RMD)
www.capitalcube.com - September 14 at 11:26 AM |
| 3 blue-chip shares that won’t let you down (ASX:RMD)
www.fool.com.au - September 10 at 6:17 PM |
| ETF’s with exposure to ResMed, Inc. : September 2, 2016 (ASX:RMD)
www.capitalcube.com - September 2 at 11:59 AM |
 | F&P Healthcare to 'vigorously contest' what's likely to be lengthy IP legal spat (ASX:RMD)
nz.finance.yahoo.com - August 23 at 7:18 PM |
 | ResMed (RMD) Stock Slides, Jefferies Downgrades to 'Underperform' (ASX:RMD)
www.thestreet.com - August 23 at 7:18 PM |
| ETF’s with exposure to ResMed, Inc. : August 18, 2016 (ASX:RMD)
www.capitalcube.com - August 18 at 7:24 PM |
| ETF’s with exposure to ResMed, Inc. : August 5, 2016 (ASX:RMD)
www.capitalcube.com - August 5 at 7:24 PM |
| Look at Medical Product Earnings on Jul 28: BSX, RMD & More (ASX:RMD)
finance.yahoo.com - July 27 at 6:59 AM |
| The easy way to start building a $1 million share portfolio in FY 2017 (ASX:RMD)
www.fool.com.au - July 20 at 10:00 AM |
 | Is Nanosonics Ltd a blue-chip share of tomorrow? (ASX:RMD)
finance.ninemsn.com.au - May 31 at 8:48 AM |
| ResMed books mixed third-quarter results (ASX:RMD)
au.finance.yahoo.com - April 26 at 8:45 PM |
| ResMed Q3 revenue up 7 pct (ASX:RMD)
au.finance.yahoo.com - April 26 at 7:42 PM |
| ResMed misses 3Q profit forecasts (ASX:RMD)
sg.finance.yahoo.com - April 26 at 5:29 PM |
 | ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2016 (ASX:RMD)
www.publicnow.com - April 26 at 4:14 PM |
| ResMed Files Patent Infringement Action Against BMC and 3B CPAP Devices (ASX:RMD)
www.publicnow.com - April 15 at 5:07 PM |
| ResMed: Strong Cash Balance, Product Portfolio Drive Growth (ASX:RMD)
finance.yahoo.com - April 8 at 2:50 PM |
| ResMed (RMD) Stock Gets 'Underweight' Rating at Barclays (ASX:RMD)
www.thestreet.com - April 7 at 9:17 AM |
 | ResMed (RMD) Announces Completion of Inova Labs Acquisition (ASX:RMD)
www.streetinsider.com - February 4 at 2:36 PM |
| Why AGL Energy Ltd & Fisher & Paykel Healthcare Corp Ltd could offer growth & income (ASX:RMD)
www.fool.com.au - February 3 at 7:19 PM |
 | ResMed Inc. (RMD) Jumped To A 6-Week High On Strong Q2 Earnings (ASX:RMD)
www.rttnews.com - January 25 at 1:15 PM |
| Why ResMed Inc's Stock Is Up Big Today (ASX:RMD)
www.fool.com - January 22 at 12:17 PM |
| Resmed lifts 2Q revenue 7% to $US454.5m (ASX:RMD)
au.finance.yahoo.com - January 21 at 5:50 PM |
| ResMed tops Street 2Q forecasts (ASX:RMD)
sg.finance.yahoo.com - January 21 at 4:46 PM |
| ResMed (RMD) Stock Downgraded at Barclays (ASX:RMD)
www.thestreet.com - January 19 at 4:19 PM |
